S&P 500   3,370.26 (-0.09%)
DOW   27,865.67 (-0.11%)
QQQ   272.17 (-0.11%)
AAPL   454.83 (-1.13%)
MSFT   208.53 (-0.08%)
FB   261.00 (-0.11%)
GOOGL   1,513.50 (-0.21%)
AMZN   3,141.66 (-0.61%)
NVDA   464.60 (+1.50%)
CGC   17.10 (-1.27%)
BABA   256.20 (+0.98%)
TSLA   1,647.56 (+1.64%)
GE   6.58 (-0.30%)
MU   45.70 (-0.95%)
AMD   82.56 (+0.88%)
T   29.92 (+0.03%)
F   7.01 (-0.28%)
GILD   68.29 (+0.16%)
NFLX   484.73 (+0.71%)
DIS   130.00 (-0.73%)
BAC   26.19 (-0.61%)
BA   173.60 (-0.65%)
S&P 500   3,370.26 (-0.09%)
DOW   27,865.67 (-0.11%)
QQQ   272.17 (-0.11%)
AAPL   454.83 (-1.13%)
MSFT   208.53 (-0.08%)
FB   261.00 (-0.11%)
GOOGL   1,513.50 (-0.21%)
AMZN   3,141.66 (-0.61%)
NVDA   464.60 (+1.50%)
CGC   17.10 (-1.27%)
BABA   256.20 (+0.98%)
TSLA   1,647.56 (+1.64%)
GE   6.58 (-0.30%)
MU   45.70 (-0.95%)
AMD   82.56 (+0.88%)
T   29.92 (+0.03%)
F   7.01 (-0.28%)
GILD   68.29 (+0.16%)
NFLX   484.73 (+0.71%)
DIS   130.00 (-0.73%)
BAC   26.19 (-0.61%)
BA   173.60 (-0.65%)
S&P 500   3,370.26 (-0.09%)
DOW   27,865.67 (-0.11%)
QQQ   272.17 (-0.11%)
AAPL   454.83 (-1.13%)
MSFT   208.53 (-0.08%)
FB   261.00 (-0.11%)
GOOGL   1,513.50 (-0.21%)
AMZN   3,141.66 (-0.61%)
NVDA   464.60 (+1.50%)
CGC   17.10 (-1.27%)
BABA   256.20 (+0.98%)
TSLA   1,647.56 (+1.64%)
GE   6.58 (-0.30%)
MU   45.70 (-0.95%)
AMD   82.56 (+0.88%)
T   29.92 (+0.03%)
F   7.01 (-0.28%)
GILD   68.29 (+0.16%)
NFLX   484.73 (+0.71%)
DIS   130.00 (-0.73%)
BAC   26.19 (-0.61%)
BA   173.60 (-0.65%)
S&P 500   3,370.26 (-0.09%)
DOW   27,865.67 (-0.11%)
QQQ   272.17 (-0.11%)
AAPL   454.83 (-1.13%)
MSFT   208.53 (-0.08%)
FB   261.00 (-0.11%)
GOOGL   1,513.50 (-0.21%)
AMZN   3,141.66 (-0.61%)
NVDA   464.60 (+1.50%)
CGC   17.10 (-1.27%)
BABA   256.20 (+0.98%)
TSLA   1,647.56 (+1.64%)
GE   6.58 (-0.30%)
MU   45.70 (-0.95%)
AMD   82.56 (+0.88%)
T   29.92 (+0.03%)
F   7.01 (-0.28%)
GILD   68.29 (+0.16%)
NFLX   484.73 (+0.71%)
DIS   130.00 (-0.73%)
BAC   26.19 (-0.61%)
BA   173.60 (-0.65%)
Log in

NASDAQ:VRMLVermillion Stock Price, Forecast & News

$4.05
-0.12 (-2.88 %)
(As of 08/14/2020 10:11 AM ET)
Add
Compare
Today's Range
$4.00
Now: $4.05
$4.20
50-Day Range
$3.43
MA: $4.14
$5.25
52-Week Range
$0.35
Now: $4.05
$5.78
Volume442,642 shs
Average Volume440,144 shs
Market Capitalization$394.38 million
P/E RatioN/A
Dividend YieldN/A
Beta3.47
Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.
Read More
Vermillion logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VRML
CUSIPN/A
Phone512-519-0400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.54 million
Book Value$0.09 per share

Profitability

Net Income$-15,240,000.00
Net Margins-307.31%

Miscellaneous

Employees43
Market Cap$394.38 million
Next Earnings DateN/A
OptionableOptionable
$4.05
-0.12 (-2.88 %)
(As of 08/14/2020 10:11 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VRML News and Ratings via Email

Sign-up to receive the latest news and ratings for VRML and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vermillion (NASDAQ:VRML) Frequently Asked Questions

How has Vermillion's stock price been impacted by COVID-19 (Coronavirus)?

Vermillion's stock was trading at $0.84 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VRML stock has increased by 382.1% and is now trading at $4.05.
View which stocks have been most impacted by COVID-19
.

How were Vermillion's earnings last quarter?

Vermillion, Inc. (NASDAQ:VRML) released its quarterly earnings results on Thursday, August, 8th. The company reported ($0.06) earnings per share (EPS) for the quarter. The business had revenue of $1.14 million for the quarter. Vermillion had a negative return on equity of 155.25% and a negative net margin of 307.31%.
View Vermillion's earnings history
.

Has Vermillion been receiving favorable news coverage?

Media headlines about VRML stock have been trending positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Vermillion earned a news sentiment score of 2.7 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future.
View the latest news about Vermillion
.

Who are some of Vermillion's key competitors?

What other stocks do shareholders of Vermillion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vermillion investors own include CombiMatrix (CBMX), Accelerate Diagnostics (AXDX), Himax Technologies (HIMX), Idera Pharmaceuticals (IDRA), Opko Health (OPK), TrovaGene (TROV), Agenus (AGEN), Charter Communications (CHTR), Fluidigm (FLDM) and Gilead Sciences (GILD).

Who are Vermillion's key executives?

Vermillion's management team includes the following people:
  • Ms. Valerie Barber Palmieri, CEO, Pres & Director (Age 58)
  • Mr. Robert Harry Beechey CPA, Chief Financial Officer (Age 56)
  • Mr. Chris Goulart, Sr. VP of Commercial Operations

What is Vermillion's stock symbol?

Vermillion trades on the NASDAQ under the ticker symbol "VRML."

How do I buy shares of Vermillion?

Shares of VRML can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vermillion's stock price today?

One share of VRML stock can currently be purchased for approximately $4.05.

How big of a company is Vermillion?

Vermillion has a market capitalization of $394.38 million and generates $4.54 million in revenue each year. Vermillion employs 43 workers across the globe.

What is Vermillion's official website?

The official website for Vermillion is www.vermillion.com.

How can I contact Vermillion?

Vermillion's mailing address is 12117 BEE CAVES ROAD BUILDING THREE SUITE 100, AUSTIN TX, 78738. The company can be reached via phone at 512-519-0400 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.